The Tauranga arm of P3 Research, which performs clinical research trials for international pharmaceutical companies, this month celebrated its 10th anniversary in the Bay with an award from longtime global client INC Research.
"The INC Research award was given to us for the quality of the work we produce and having a clinical trials site dedicated to excellence," said P3's local research manager Katie Kennett, who runs the Tauranga site.
P3 Research was founded in Wellington in 1998, expanded into the Bay in 2005, and recently opened a site in Hawke's Bay.
"We perform clinical trials for international companies and contract research organisations and also undertake some clinical research for individual researchers," said Ms Kennett, a registered nurse who has been involved in clinical research for two decades.
The company is capable of performing a range of studies from small scale early Phase 2 trials to long-term Phase 3 studies and post-marketing investigations. P3 Research also performs research into issues such as patient compliance and the development of delivery devices. Before they can be licensed by international bodies such as the US Food and Drug Administration (FDA), new medications go through several stages of trials.
